2m 2m 2m 2m 2m 2m 2m
ABEONA THERAP (ABEO)
NASDAQ
$6.10+$0.010 (+0.16%)
Price as of Aug 21, 2026 7:30 PM EDT- $348.3MMarket Cap
- -15.77%1-Year Change
- BiotechnologyIndustry
ABEONA THERAP (ABEO)
$6.10+$0.010 (+0.16%)
ABEO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $6.09 | ||
Change | +$0.13 (+2.18%) | ||
Open | $6.03 | ||
High | $6.14 | ||
Low | $6.01 | ||
Previous Close | $5.96 | ||
Volume | 894,799 | ||
30-Day Average Volume | 1,549,697 | ||
1-Week Change | 1.75% | ||
1-Month Change | -6.74% | ||
1-Year Change | -15.77% | ||
3-Year Change | 60.69% | ||
5-Year Change | -79.18% | ||
Fundamentals | |||
Shares Outstanding | 57.2M | ||
Total Assets | $179.5M | ||
Market Cap | $348.3M | ||
Enterprise Value | $307.0M | ||
Period: QTR TTM FY | |||
Revenue | $1.4M | ||
Net Income | -$20.2M | ||
Free Cash Flow | -$18.0M | ||
EBIT | -$19.6M | ||
EBITDA | -$18.9M | ||
Net Working Capital | $139.8M | ||
EPS | -$0.35 | ||
Enterprise Value/EBITDA | -16 | ||
Enterprise Value/Revenue | 227 | ||
P/B | 3 | ||
P/E | -17 | ||
PEG | 1 | ||
Price/Free Cash Flow | -19 | ||
Price/Operating Cash Flow | -20 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 25 | ||
Last Split Date | 07/05/2022 | ||
Earnings & Revenue